New drug INCA036978 enters human testing for rare blood cancers
NCT ID NCT07441694
First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times
Summary
This early-stage study tests an experimental drug, INCA036978, in about 218 adults with myeloproliferative neoplasms (a group of blood cancers). The main goal is to check the drug's safety and find the best dose, either alone or with standard treatment. Participants must have a life expectancy over 6 months and cannot have other recent cancers or serious infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
A. Gemelli University Hospital, Catholic University of the Sacred Heart
NOT_YET_RECRUITINGRoma, 00168, Italy
-
AZ DELTA
NOT_YET_RECRUITINGRoeselare, 08800, Belgium
-
Aou Policlinico S. Orsola-Malpighi
NOT_YET_RECRUITINGBologna, 40138, Italy
-
Azienda Sanitaria Universitaria Friuli Centrale Asu Fc
NOT_YET_RECRUITINGUdine, 33100, Italy
-
Centre Hospitalier Universitaire (Chu) de Liege
NOT_YET_RECRUITINGLiège, 04000, Belgium
-
Charite Universitaetsmedizin Berlin - Campus Charite Mitte
NOT_YET_RECRUITINGBerlin, 10117, Germany
-
City of Hope-Lennar Foundation Cancer Center
NOT_YET_RECRUITINGIrvine, California, 92618, United States
-
Cleveland Clinic
NOT_YET_RECRUITINGCleveland, Ohio, 44195, United States
-
Concord General Repatriation Hospital
RECRUITINGConcord, New South Wales, 02139, Australia
-
Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy
NOT_YET_RECRUITINGDurham, North Carolina, 27705, United States
-
Ehime University Hospital
NOT_YET_RECRUITINGToon, Ehime, 791-0204, Japan
-
Epworth Health Care
RECRUITINGEast Melbourne, Victoria, 03002, Australia
-
Fondazione Irccs Ca' Granda - Ospedale Maggiore Policlinico
NOT_YET_RECRUITINGMilan, 20122, Italy
-
Guy'S Hospital - Guy'S & St Thomas' Nhs Foundation Trust
NOT_YET_RECRUITINGLondon, SE1 9RT, United Kingdom
-
Hospital Saint Louis
NOT_YET_RECRUITINGParis, 75010, France
-
Hospital Universitari Germans Trias I Pujol
NOT_YET_RECRUITINGBadalona, 08916, Spain
-
Hospital Universitario 12 de Octubre
NOT_YET_RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario de Gran Canaria Dr. Negrin
NOT_YET_RECRUITINGLas Palmas de Gran Canaria, 35010, Spain
-
Huntsman Cancer Institute
NOT_YET_RECRUITINGSalt Lake City, Utah, 84112, United States
-
Icon Cancer Centre
RECRUITINGAuchenflower, Queensland, 04066, Australia
-
Institut Bergonie
NOT_YET_RECRUITINGBordeaux, 33076, France
-
Institut Gustave Roussy
NOT_YET_RECRUITINGVillejuif, 94805, France
-
John Hopkins Hospital
NOT_YET_RECRUITINGBaltimore, Maryland, 21287, United States
-
Levine Cancer Institute
NOT_YET_RECRUITINGCharlotte, North Carolina, 28204, United States
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, 06009, Australia
-
Massachusetts General Hospital
NOT_YET_RECRUITINGBoston, Massachusetts, 02114, United States
-
McGill University Jewish General Hospital
NOT_YET_RECRUITINGMontreal, Quebec, H3T 1E2, Canada
-
Medical College of Wisconsin
NOT_YET_RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering Cancer Center
NOT_YET_RECRUITINGNew York, New York, 10021, United States
-
Moffitt Cancer Center
NOT_YET_RECRUITINGTampa, Florida, 33612, United States
-
Mount Sinai School of Medicine
NOT_YET_RECRUITINGNew York, New York, 10029, United States
-
National Cancer Center Hospital East
NOT_YET_RECRUITINGKashiwa Chiba, 277-0882, Japan
-
Nottingham University Hospitals
NOT_YET_RECRUITINGNottingham, NG5 1PB, United Kingdom
-
Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
-
Princess Margaret Cancer Center
NOT_YET_RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Royal North Shore Hospital
RECRUITINGSt Leonards, New South Wales, 02065, Australia
-
Seoul National University Hospital
NOT_YET_RECRUITINGJongno-gu, Seoul, 03080, South Korea
-
The Catholic University of Korea Seoul St. Mary'S Hospital
NOT_YET_RECRUITINGSeocho-gu, Seoul, 06591, South Korea
-
Tristar Bmt/Tcto
RECRUITINGNashville, Tennessee, 37203, United States
-
UCLA Medical Hematology & Oncology
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
-
Universitatklinikum Freiburg
NOT_YET_RECRUITINGFreiburg im Breisgau, 79106, Germany
-
Universitatsklinikum Halle (Saale)
NOT_YET_RECRUITINGHalle, 06120, Germany
-
Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii
NOT_YET_RECRUITINGMainz, 55131, Germany
-
University Medical Center Rwth Aachen
NOT_YET_RECRUITINGAachen, D-52074, Germany
-
University of Alabama At Birmingham
NOT_YET_RECRUITINGBirmingham, Alabama, 35233, United States
-
University of Miami
NOT_YET_RECRUITINGMiami, Florida, 33136, United States
-
University of North Carolina At Chapel Hill
NOT_YET_RECRUITINGChapel Hill, North Carolina, 27514, United States
-
University of Oxford
NOT_YET_RECRUITINGOxford, OX3 7LE, United Kingdom
-
University of Texas M. D. Anderson Cancer Center
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
-
Usc Norris Comprehensive Cancer Center
NOT_YET_RECRUITINGLos Angeles, California, 90033, United States
-
Washington University School of Medicine
NOT_YET_RECRUITINGSt Louis, Missouri, 63108, United States
-
Weill Cornell Medicine
NOT_YET_RECRUITINGNew York, New York, 10065, United States
-
Winship Cancer Institute of Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
-
Yale Cancer Center
NOT_YET_RECRUITINGNew Haven, Connecticut, 06510, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill shrink the spleen and ease myelofibrosis symptoms?
- Can a new pill tame myelofibrosis?
- MRI as a window into bone marrow disease: a new biomarker test?
- Can a menin inhibitor tame myelofibrosis when standard drugs fall short?
- Can a drug free myelofibrosis patients from frequent blood transfusions?
- Heart safety check for new myelofibrosis drug in healthy volunteers